Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine how two different types of iodinated contrast media
(CM) agents, low-osmolar ionic ioxaglate and iso-osmolar non-ionic iodixanol, affect specific
markers of thrombogenesis and platelet function in patients undergoing coronary angiography,
and if the use of bivalirudin, a direct thrombin inhibitor used during percutaneous coronary
intervention (PCI), affects any contrast-related changes in thrombogenesis and platelet
function.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health